Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3748/wjg.v22.i39.8720 http://scihub22266oqcxt.onion/10.3748/wjg.v22.i39.8720 C5075547!5075547 !27818588     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27818588 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27818588 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       World+J+Gastroenterol 2016 ; 22 (39 ): 8720-8734 Nephropedia Template TP {{tp|p=27818588 |t=2016. Update on occult hepatitis B virus infection |pdf=|usr=}}{{27818588 }} gab.com Text Update on occult hepatitis B virus infection JO: World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=27818588 #FOAvip The event of mutations in the surface antigen gene of hepatitis B virus (HBV) results in undetectable hepatitis B surface antigen with positive/negative anti-hepatitis B core (anti-HBc) antibody status in serum and this phenomenon is named occult hepatitis B infection (OBI). The presence of anti-HBc antibody in serum is an important key for OBI tracking, although about 20% of OBI cases are negative for anti-HBc antibody. The diagnosis of OBI is mainly based on polymerase chain reaction (PCR) and real-time PCR assays. However, real-time PCR is a more reliable method than PCR. OBI is a great issue for the public health problem and a challenge for the clinical entity worldwide. The persistence of OBI may lead to the development of cirrhosis and hepatocellular carcinoma. With regard to OBI complications, the screening of HBV DNA by the highly sensitive molecular means should be implemented for: (1) patients with a previous history of chronic or acute HBV infection; (2) patients co-infected with hepatitis C virus/human immunodeficiency virus; (3) patients undergoing chemotherapy or anti-CD20 therapy; (4) recipients of organ transplant; (5) blood donors; (6) organ transplant donors; (7) thalassemia and hemophilia patients; (8) health care workers; (9) patients with liver related disease (cryptogenic); (10) hemodialysis patients; (11) patients undergoing lamivudine or interferon therapy; and (12) children in time of HBV vaccination especially in highly endemic areas of HBV. Active HBV vaccination should be implemented for the close relatives of patients who are negative for OBI markers. Thus, the goal of this review is to evaluate the rate of OBI with a focus on status of high risk groups in different regions of the world. Twit Text FOAVip Update on occult hepatitis B virus infection ????World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=27818588 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27818588 #FOAvip English Wikipedia <ref>{{Cite pmid|27818588 }}</ref> Update on occult hepatitis B virus infection #MMPMID27818588 Makvandi M World J Gastroenterol 2016[Oct]; 22 (39 ): 8720-8734 PMID27818588 show ga The event of mutations in the surface antigen gene of hepatitis B virus (HBV) results in undetectable hepatitis B surface antigen with positive/negative anti-hepatitis B core (anti-HBc) antibody status in serum and this phenomenon is named occult hepatitis B infection (OBI). The presence of anti-HBc antibody in serum is an important key for OBI tracking, although about 20% of OBI cases are negative for anti-HBc antibody. The diagnosis of OBI is mainly based on polymerase chain reaction (PCR) and real-time PCR assays. However, real-time PCR is a more reliable method than PCR. OBI is a great issue for the public health problem and a challenge for the clinical entity worldwide. The persistence of OBI may lead to the development of cirrhosis and hepatocellular carcinoma. With regard to OBI complications, the screening of HBV DNA by the highly sensitive molecular means should be implemented for: (1) patients with a previous history of chronic or acute HBV infection; (2) patients co-infected with hepatitis C virus/human immunodeficiency virus; (3) patients undergoing chemotherapy or anti-CD20 therapy; (4) recipients of organ transplant; (5) blood donors; (6) organ transplant donors; (7) thalassemia and hemophilia patients; (8) health care workers; (9) patients with liver related disease (cryptogenic); (10) hemodialysis patients; (11) patients undergoing lamivudine or interferon therapy; and (12) children in time of HBV vaccination especially in highly endemic areas of HBV. Active HBV vaccination should be implemented for the close relatives of patients who are negative for OBI markers. Thus, the goal of this review is to evaluate the rate of OBI with a focus on status of high risk groups in different regions of the world. |Antiviral Agents/therapeutic use [MESH] |Coinfection [MESH] |DNA, Viral/*blood [MESH] |HIV Infections/*complications/epidemiology/therapy [MESH] |Hepatitis B Antibodies/blood [MESH] |Hepatitis B Surface Antigens/blood [MESH] |Hepatitis B virus/*genetics [MESH] |Hepatitis B/*complications/epidemiology/therapy [MESH] |Humans [MESH] |Interferons/therapeutic use [MESH] |Lamivudine/therapeutic use [MESH] |Liver Cirrhosis/complications/virology [MESH] |Liver Transplantation [MESH] |Mutation [MESH] |Occupational Exposure [MESH] |Prevalence [MESH] |RNA Splicing [MESH] |Renal Dialysis [MESH]Update on occult hepatitis B virus infection (epmc).pdf DeepDyve Pubget Overpricing